title: Immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC 45662).
authors.affiliation: Department of Medicine, University of Maryland Hospital, Baltimore 21201.
authors.forename: M R
authors.initials: MR
authors.lastname: Weir
authors.forename: X W
authors.initials: XW
authors.lastname: Li
authors.forename: D
authors.initials: D
authors.lastname: Gomolka
authors.forename: R
authors.initials: R
authors.lastname: Peppler
authors.forename: G
authors.initials: G
authors.lastname: O'Bryan-Tear
authors.forename: M
authors.initials: M
authors.lastname: Moran
mesh_terms: D000085:Acetates; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000494:pharmacology; D001094:Arachidonate 5-Lipoxygenase / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis; D007694:Killer Cells, Natural / Q000276:immunology; D016859:Lipoxygenase Inhibitors; D008213:Lymphocyte Activation / Q000187:drug effects; D010636:Phenols; D015375:Receptors, Interleukin-2 / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D000085:Acetates; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D016859:Lipoxygenase Inhibitors; D010636:Phenols; D015375:Receptors, Interleukin-2; C066992:(2-((3,5-di-t-butyl-4-hydroxyphenyl)thio)-1-methylpropoxy)acetic acid; D001094:Arachidonate 5-Lipoxygenase; D000527:Alprostadil; C054594:enisoprost